LY3852710 for Chronic Pain

Phase-Based Progress Estimates
1
Effectiveness
2
Safety
Chronic Pain+2 MoreLY3852710 - Drug
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This study is being done to test the safety and efficacy of the study drug LY3852710 for the treatment of diabetic peripheral neuropathic pain.

Eligible Conditions
  • Chronic Pain
  • Diabetic Neuropathy

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 6 Secondary · Reporting Duration: Baseline, Up to Week 8

Week 8
Change from Baseline for Overall Improvement as Measured by Patient's Global Impression of Change
Pain
Change from Baseline in Average Pain Intensity as Measured by the Numeric Rating Scale (NRS)
Change from Baseline in the Brief Pain Inventory-Short Form (BPI-SF) Total Interference Score
Change from Baseline on the EuroQol-5D 5 Level Questionnaire (EQ-5D-5L)
Change from Baseline on the Sleep Scale from the Medical Outcomes Study (MOS Sleep Scale)
Change from Baseline on the Visual Analog Scale (VAS) for Pain

Trial Safety

Safety Progress

2 of 3
This is further along than 68% of similar trials

Trial Design

2 Treatment Groups

LY3852710
1 of 2
Placebo
1 of 2

Experimental Treatment

Non-Treatment Group

125 Total Participants · 2 Treatment Groups

Primary Treatment: LY3852710 · Has Placebo Group · Phase 2

LY3852710
Drug
Experimental Group · 1 Intervention: LY3852710 · Intervention Types: Drug
Placebo
Drug
PlaceboComparator Group · 1 Intervention: Placebo · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, up to week 8

Who is running the clinical trial?

Eli Lilly and CompanyLead Sponsor
2,466 Previous Clinical Trials
3,135,277 Total Patients Enrolled
7 Trials studying Chronic Pain
1,228 Patients Enrolled for Chronic Pain
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)Study DirectorEli Lilly and Company
1,258 Previous Clinical Trials
369,273 Total Patients Enrolled
3 Trials studying Chronic Pain
354 Patients Enrolled for Chronic Pain

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are not required to use a male contraceptive.\n
The study will be conducted in accordance with the rules and regulations of the local ethical committee.

Who else is applying?

What state do they live in?
Nevada50.0%
Georgia50.0%
What portion of applicants met pre-screening criteria?
Met criteria50.0%
Did not meet criteria50.0%
What site did they apply to?
Artemis Institute for Clinical Research100.0%
Why did patients apply to this trial?
  • "being able to be a part of a research to help with chronic pain to help get it out to the world. To be a part of a better cause and new solution."
How many prior treatments have patients received?
0100.0%